Back to Results
First PageMeta Content
Staphylococcaceae / Bacterial diseases / Microbiology / Antibiotic-resistant bacteria / Methicillin-resistant Staphylococcus aureus / Antibiotics / Nosocomial infection / Staphylococcus aureus / Antibiotic resistance / Bacteria / Medicine / Biology


Reply to ''Planned Analyses of the REDUCE MRSA Trial'' Kevin T. Kavanagh, Daniel M. Saman and Yanling Yu Antimicrob. Agents Chemother. 2014, 58(4):2486. DOI: AAC.
Add to Reading List

Document Date: 2014-03-19 15:00:36


Open Document

File Size: 463,53 KB

Share Result on Facebook

City

Seattle / Hartford / Helsinki / Somerset / /

Company

Derde LP / USAa / /

Country

United States / /

/

Facility

Essentia Institute of Rural / /

IndustryTerm

unit-wide chlorhexidine decolonization protocols / /

MedicalCondition

ICU infection / MRSA infections / Central-line-associated bloodstream infections / ICU-attributable all-pathogen bloodstream infection / /

MedicalTreatment

antibiotics / /

Organization

Center for Disease Dynamics / Economics & Policy / American Society for Microbiology / FDA / Washington Advocates for Patient Safety / Essentia Institute of Rural / /

Person

Daniel M. Saman / Platt / Washington Advocates / Huang / Alastair Wood / /

Position

AUTHOR / lead author / /

ProvinceOrState

Kentucky / Minnesota / /

PublishedMedium

Antimicrobial Agents and Chemotherapy / /

Region

Northern Europe / /

Technology

Chemotherapy / unit-wide chlorhexidine decolonization protocols / http / /

URL

http /

SocialTag